Dhar, R. et al. 2024. Triple Fixed-dose combination of Dapagliflozin, Sitagliptin, and Metformin for People with Type 2 Diabetes in Indian Settings. Journal of Drug Delivery and Therapeutics. 14, 9 (Sep. 2024), 66–73. DOI:https://doi.org/10.22270/jddt.v14i9.6692.